NLRP3 and Alzheimer disease: Indeed, this hypothesis is supported by studies on Rhodiola glycosides in AD therapy, which exerted its therapeutic effects by inhibiting NLRP3 inflammasome-mediated pyroptosis (Cai et al., 2021).